Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease
- PMID: 10463718
- DOI: 10.1001/jama.282.8.786
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
